AstraZeneca Pharma India (ASTRAZEN.BO) Earnings Analysis
AstraZeneca Pharma India (ASTRAZEN.BO) has no confirmed upcoming earnings date. Last quarter (2026-05-28) it beat with EPS 17.95 INR vs 5.16 INR est (+247.9%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 105.25.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ASTRAZEN.BO next report earnings?
No confirmed upcoming earnings date is currently scheduled for ASTRAZEN.BO. This page updates as the calendar is published.
ASTRAZEN.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-28 | 17.95 INR | 5.16 INR | +247.9% | Beat |
| 2026-02-09 | 13.04 INR | 8.29 INR | +57.3% | Beat |
| 2025-08-14 | 22.33 INR | 8.29 INR | +169.4% | Beat |
| 2025-05-30 | 23.3 INR | 5.16 INR | +351.6% | Beat |
Beat rate: 4/4 (100%) over reported quarters with consensus data.
ASTRAZEN.BO valuation and analyst view
| Trailing P/E | 105.25 |
|---|---|
| Trailing EPS | 74.999 INR |
| Price / book | 22.62 |
| Dividend yield | 0.41% |
| Market cap | 200.85B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is AstraZeneca Pharma India (ASTRAZEN.BO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ASTRAZEN.BO. This page updates as the calendar is published.
Did ASTRAZEN.BO beat earnings last quarter?
In its 2026-05-28 report, ASTRAZEN.BO posted EPS of 17.95 INR versus a 5.16 INR estimate — a beat of 247.9%.
What is ASTRAZEN.BO's earnings track record?
Over the last 4 reported quarters with consensus data, ASTRAZEN.BO beat estimates 4 times (100%).
What is ASTRAZEN.BO's current P/E ratio and EPS?
ASTRAZEN.BO trades at a trailing P/E of 105.25 on trailing EPS of 74.9990001199856 INR.
What do analysts rate ASTRAZEN.BO?
ASTRAZEN.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.